Last update 04 Nov 2024

Adalimumab Biosimilar (Henlius Biotech)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
HLX 03, HLX-03, 汉达远
Target
Mechanism
TNF-α inhibitors(Tumor necrosis factor α inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pediatric Crohn's Disease
CN
22 May 2024
Plaque psoriasis
CN
22 May 2024
Polyarticular Juvenile Idiopathic Arthritis
CN
22 May 2024
Uveitis
CN
12 Apr 2021
Ankylosing Spondylitis
CN
02 Dec 2020
Psoriasis
CN
02 Dec 2020
Rheumatoid Arthritis
CN
02 Dec 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
262
(HLX03 group)
sgtjumjang(ctboyphhnv) = iapyfifnnr avbexljqhu (sdvwotfpke )
Positive
23 Nov 2021
(adalimumab group)
sgtjumjang(ctboyphhnv) = gplzowicyu avbexljqhu (sdvwotfpke )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free